(19)
(11) EP 3 983 011 A1

(12)

(43) Date of publication:
20.04.2022 Bulletin 2022/16

(21) Application number: 20731142.4

(22) Date of filing: 12.06.2020
(51) International Patent Classification (IPC): 
A61K 39/04(2006.01)
A61P 31/06(2006.01)
(52) Cooperative Patent Classification (CPC):
A61K 39/04; A61P 31/06; A61K 2039/55555; C07K 2319/00; A61K 2039/572; A61K 2039/6068; A61K 2039/6018
(86) International application number:
PCT/EP2020/066343
(87) International publication number:
WO 2020/249756 (17.12.2020 Gazette 2020/51)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
KH MA MD TN

(30) Priority: 14.06.2019 EP 19180280

(71) Applicant: Statens Serum Institut
DK-2300 Copenhagen S (DK)

(72) Inventors:
  • MORTENSEN, Rasmus
    2650 Hvidovre (DK)
  • AAGAARD, Claus
    2300 Copenhagen s (DK)
  • ANDERSEN, Peter Lawætz
    2700 Brønshøj (DK)

(74) Representative: Plougmann Vingtoft a/s 
Strandvejen 70
2900 Hellerup
2900 Hellerup (DK)

   


(54) FUSION PROTEINS FOR TUBERCULOSIS VACCINES